We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
    • Leafly.deGerman flag
  • Help
  • News
  • Lifestyle
  • Strains & products
  • Industry
  • Growing
  • Health
  • Science & tech
  • Leafly USA
  • Podcasts
  • Learn
Politics

Did a Massachusetts Senate Panel Mislead Voters About Legalization?

Gage PeakePublished on October 13, 2016 · Last updated July 28, 2020

Cannabis supporters in the legalization-battleground state of Massachusetts are pushing back against a state Senate report, claiming its “misconstrued statistics and unfounded speculation” have misinformed voters about legalization in the lead-up to November’s election.

The report, published in March, was the result of Colorado trip taken by members of the Special Senate Committee on Marijuana to see the legal cannabis industry for themselves. After roughly a year of work, the Herald News reports, the committee released a report that was highly critical of the Massachusetts ballot measure, Question 4.

“The Report covers a wide range of important issues,” begins the Yes on 4 campaign’s rebuttal, released this week, “but however well-intentioned, it is flawed because it contains inaccuracies and speculative conclusions concerning the implications of regulating recreational marijuana.”

The lawmaker who led the Senate committee, Sen. Jason Lewis (D-Winchester) is now part of a steering committee for the Campaign for a Safe and Healthy Massachusetts, a group formed by Gov. Charlie Baker, Boston Mayor Marty Walsh, and House Speaker Robert DeLeo.

That coalition of officials has lobbed questionable claims at legalization, too, arguing that cannabis is a “gateway drug” and warning that legalization would lead to more teens consuming cannabis and could worsen the state’s opioid epidemic. Based on available evidence, none of those claims is true.

Voters at the polls next month, it continued, “Voters at the polls in November should base their decisions on facts and sound policy arguments rather than the misconstrued statistics and unfounded speculation of misinformed public officials,” the Yes campaign said.

Lewis, for his part, released a statement saying that he was “confident that we produced a thorough, comprehensive, fair and balanced report.” The rebuttal, he said, was “authored by a law firm who is a hired gun for the commercial cannabis industry.”

Observers across the country are watching to see how Massachusetts voters decide Question 4. Travel writer and PBS host Rick Steves is in the state this week talking to audiences about what he’s seen in his home state of Washington as well as other legal states, such as Colorado and Oregon. On Wednesday the mild-mannered 51-year-old levied a harsh criticism of Massachusetts lawmakers.

When it comes to cannabis, he told a crowd in Boston, “Your legislators don’t have the courage to learn about it.”

Related Stories

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
adult-use cannabisElection 2016legalizationmassachusettspolitics
Gage Peake
Gage Peake
Gage Peake is a former staff writer for Leafly, where he specialized in data journalism, sports, and breaking news coverage. He's a graduate of the University of Nebraska-Lincoln's College of Journalism and Mass Communications.
View Gage Peake's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.